ArticleEcancermedicalscience2024

Unravelling Eribulin's role in metastatic breast cancer: evaluating benefits for both triple negative and non-triple negative patients in real-world scenarios in resource-constrained settings.

Akhil Kapoor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.